首页 正文

Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis

{{output}}
Psoriasis vulgaris is a chronic, immune-mediated systemic disease that affectŝ7.5 million people in the US. It can be treated with many therapies, often in combination, which include topicals, phototherapy, oral systemics, and biologics. Biologic agents targe... ...